Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

576.70INR
5:28am EST
Change (% chg)

Rs-7.05 (-1.21%)
Prev Close
Rs583.75
Open
Rs586.00
Day's High
Rs589.45
Day's Low
Rs574.30
Volume
3,679,687
Avg. Vol
4,917,950
52-wk High
Rs729.05
52-wk Low
Rs432.70

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.
Tuesday, 16 Jan 2018 08:38am EST 

Jan 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS CO'S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC.ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US.COMPANIES TO GRANT CO'S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES.ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED..  Full Article

Allergan, Ironwood Announce Settlement With Sun Pharma
Tuesday, 16 Jan 2018 08:30am EST 

Jan 16 (Reuters) - Allergan Plc ::IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH SUN PHARMA RESOLVING LINZESS® (LINACLOTIDE) PATENT LITIGATION.SAYS PER SETTLEMENT TERMS, IRONWOOD, CO TO GRANT UNITS OF SUN PHARMA LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S. BEGINNING FEB 1, 2031​.SAYS ‍ADDITIONAL DETAILS REGARDING SETTLEMENT WERE NOT DISCLOSED​.SAYS IRONWOOD PHARMACEUTICALS, CO ANNOUNCED COMPANIES REACHED AN AGREEMENT WITH WHOLLY-OWNED UNITS OF SUN PHARMACEUTICAL INDUSTRIES.SAYS ‍AS A RESULT OF SETTLEMENT, ALL HATCH-WAXMAN LITIGATION BETWEEN COMPANIES AND SUN PHARMA REGARDING LINZESS PATENTS TO BE DISMISSED​.  Full Article

Sun Pharmaceutical Industries Announces U.S FDA Acceptance Of NDA For OTX-101
Tuesday, 26 Dec 2017 10:04pm EST 

Dec 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::ANNOUNCES U.S FDA ACCEPTANCE OF NDA FOR OTX-101.  Full Article

Beijing Science Sun Pharmaceutical obtains high-tech enterprise recognition and to enjoy tax preference
Monday, 25 Dec 2017 09:53pm EST 

Dec 26(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Sun Pharma Industries MD says no new updates on Halol; awaiting FDA re-inspection of plants‍​
Tuesday, 14 Nov 2017 08:15am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries managing director Dilip Shanghvi says::No new updates on halol, awaiting FDA reinspection of plants‍​.  Full Article

Sun Pharma Industries says co expects performance to improve in H2 FY17-18
Tuesday, 14 Nov 2017 06:40am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says challenging U.S. pricing environment, investments in building global specialty business hit Q2 performance‍​.Says co expects performance to gradually improve in second half of the year.  Full Article

India's Sun Pharmaceutical Industries Sept-qtr consol profit falls 59 pct
Tuesday, 14 Nov 2017 05:27am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Sept quarter consol net profit 9.12 billion rupees versus profit of 22.35 billion rupees last year.Consensus forecast for Sept quarter consol profit was 8.27 billion rupees.Sept quarter consol total revenue from operations 66.50 billion rupees versus 82.60 billion rupees last year.  Full Article

Beijing Science Sun Pharmaceutical announces change in accounting policy
Thursday, 26 Oct 2017 06:19am EDT 

Oct 26(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it changes accounting policy based on accounting standards for business enterprises No. 16—government subsidies, which was disclosed by the Ministry of Finance on May 10, effective June 12.  Full Article

Sun Pharmaceutical Industries gets U.S.FDA nod for generic Coreg CR‍​
Thursday, 26 Oct 2017 04:13am EDT 

Oct 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says gets U.S.FDA nod for generic Coreg CR‍​.  Full Article

Sun Pharmaceutical Industries says unit raises shareholding in Ranbaxy Malaysia Sdn Bhd
Thursday, 12 Oct 2017 06:40am EDT 

Oct 12 (Reuters) - Sun Pharmaceutical Industries Ltd :Unit agreed to increase shareholding in Ranbaxy Malaysia Sdn Bhd via purchase of 666,985 shares of Ranbaxy Malaysia.  Full Article

BRIEF-Allergan, Ironwood Announce Settlement With Sun Pharma

* IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH SUN PHARMA RESOLVING LINZESS® (LINACLOTIDE) PATENT LITIGATION